Idioma:

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

Merlevede, Jane ; Droin, Nathalie ; Qin, Tingting ; Meldi, Kristen ; Yoshida, Kenichi ; Morabito, Margot ; Chautard, Emilie ; Auboeuf, Didier ; Fenaux, Pierre ; Braun, Thorsten ; Itzykson, Raphael ; de Botton, Stéphane ; Quesnel, Bruno ; Commes, Thérèse ; Jourdan, Eric ; Vainchenker, William ; Bernard, Olivier ; Pata-Merci, Noemie ; Solier, Stéphanie ; Gayevskiy, Velimir ; Dinger, Marcel E ; Cowley, Mark J ; Selimoglu-Buet, Dorothée ; Meyer, Vincent ; Artiguenave, François ; Deleuze, Jean-François ; Preudhomme, Claude ; Stratton, Michael R ; Alexandrov, Ludmil B ; Padron, Eric ; Ogawa, Seishi ; Koscielny, Serge ; Figueroa, Maria ; Solary, Eric

Nature communications, 2016-02, Vol.7 (1), p.10767-10767, Article 10767 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por

Enviar para

Título:
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Autor: Merlevede, Jane ; Droin, Nathalie ; Qin, Tingting ; Meldi, Kristen ; Yoshida, Kenichi ; Morabito, Margot ; Chautard, Emilie ; Auboeuf, Didier ; Fenaux, Pierre ; Braun, Thorsten ; Itzykson, Raphael ; de Botton, Stéphane ; Quesnel, Bruno ; Commes, Thérèse ; Jourdan, Eric ; Vainchenker, William ; Bernard, Olivier ; Pata-Merci, Noemie ; Solier, Stéphanie ; Gayevskiy, Velimir ; Dinger, Marcel E ; Cowley, Mark J ; Selimoglu-Buet, Dorothée ; Meyer, Vincent ; Artiguenave, François ; Deleuze, Jean-François ; Preudhomme, Claude ; Stratton, Michael R ; Alexandrov, Ludmil B ; Padron, Eric ; Ogawa, Seishi ; Koscielny, Serge ; Figueroa, Maria ; Solary, Eric
Assuntos: Aged ; Aged, 80 and over ; Aged, 80 and over Alleles Antimetabolites, Antineoplastic / pharmacology Antimetabolites, Antineoplastic / therapeutic use Azacitidine / analogs & derivatives Azacitidine / pharmacology Azacitidine / therapeutic use Cell Survival / drug effects DNA Methylation / drug effects Decitabine Epigenesis, Genetic / drug effects Female Gene Expression Regulation, Neoplastic / drug effects HEK293 Cells High-Throughput Nucleotide Sequencing Humans Leukemia, Myelomonocytic, Chronic / drug therapy Leukemia, Myelomonocytic, Chronic / genetics Male Middle Aged Mutation ; Alleles ; Antimetabolites, Antineoplastic - pharmacology ; Antimetabolites, Antineoplastic - therapeutic use ; Azacitidine - analogs & derivatives ; Azacitidine - pharmacology ; Azacitidine - therapeutic use ; BASIC BIOLOGICAL SCIENCES ; biological sciences ; cancer ; Cell Survival - drug effects ; DNA Methylation - drug effects ; Epigenesis, Genetic - drug effects ; Female ; Gene Expression Regulation, Neoplastic - drug effects ; genetics ; HEK293 Cells ; High-Throughput Nucleotide Sequencing ; Humans ; Leukemia, Myelomonocytic, Chronic - drug therapy ; Leukemia, Myelomonocytic, Chronic - genetics ; Life Sciences ; Male ; Middle Aged ; Mutation ; Sequence Analysis, DNA ; Sequence Analysis, RNA
É parte de: Nature communications, 2016-02, Vol.7 (1), p.10767-10767, Article 10767
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC4770084
USDOE
LA-UR-15-24070
AC52-06NA25396
These authors contributed equally to this work.
Descrição: The cytidine analogues azacytidine and 5-aza-2'-deoxycytidine (decitabine) are commonly used to treat myelodysplastic syndromes, with or without a myeloproliferative component. It remains unclear whether the response to these hypomethylating agents results from a cytotoxic or an epigenetic effect. In this study, we address this question in chronic myelomonocytic leukaemia. We describe a comprehensive analysis of the mutational landscape of these tumours, combining whole-exome and whole-genome sequencing. We identify an average of 14±5 somatic mutations in coding sequences of sorted monocyte DNA and the signatures of three mutational processes. Serial sequencing demonstrates that the response to hypomethylating agents is associated with changes in DNA methylation and gene expression, without any decrease in the mutation allele burden, nor prevention of new genetic alteration occurence. Our findings indicate that cytosine analogues restore a balanced haematopoiesis without decreasing the size of the mutated clone, arguing for a predominantly epigenetic effect.
Editor: England: Nature Publishing Group
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

England: Nature Publishing Group

Buscando em bases de dados remotas. Favor aguardar.